The Uncharted Cancer Patient Masterclass

  • Home
  • The Uncharted Cancer Patient Masterclass

The Uncharted Cancer Patient Masterclass Created to help every cancer patient. It’s free. We’re changing the future of cancer for everyone. The patients. The families. The scientists. The doctors.

Get scientifically valid cancer education created by scientists, researchers, and oncologists to understand your cancer, take control of your life, and improve your outcome. Everyone who has been told that cancer will never be cured - and refuse to accept that. Everyone that understands that the system is broken and won’t change by itself. We’re changing the future of cancer for them.

Cancer science is overwhelming and always changing. Get immediate access to the latest cancer science and action plans t...
08/12/2021

Cancer science is overwhelming and always changing. Get immediate access to the latest cancer science and action plans to improve your life and outcome. Supported by amazing donors, it's free for everyone. https://unchartedhealth.org

   Changing the future of cancer for patients. GET THE CANCER PATIENT MASTERCLASS - IT’S FREE Get scientifically valid cancer education created by scientists, researchers, and oncologists to understand your cancer, take control of your life, and improve your outcome. Created to help every cancer...

McKinsey taught Big Pharma how to price-gougeThe sleaze begins about a decade ago, when analysts started warning that ph...
28/11/2021

McKinsey taught Big Pharma how to price-gouge
The sleaze begins about a decade ago, when analysts started warning that pharma’s profits were in danger because the companies were no longer making any real breakthroughs. https://doctorow.medium.com/mckinsey-taught-big-pharma-how-to-price-gouge-364dcc89f26e

This is the ecosystem that every cancer patient has to deal with.

Leaked slides document the lies, sleaze and profiteering.

20/11/2021

Manual delivery of care means that we're locked in to systems that are simplified and focus on drug selection, without the ability to manage the complexity and individualization that precision care needs. Current cancer drugs are good, but we're able to do so much more than current standard of care which locks us in to terrible care pathways that - for advanced cancers - always lead to drug progression and death. We can do better for everyone. Fortunately, the technologies now exist to deal with the complexity required to treat every patient individually.
https://storylinehealth.com

For cancer: https://unchartedhealth.org

19/11/2021

Chris Gregg PhD discusses how and why current cancer care is broken for patients and always leads to drug resistance and death. Learn more at https://unchartedhealth.org

Cancer care is undergoing a shift from simple decisions about cancer drugs, to integrated care pathways that treat the e...
19/11/2021

Cancer care is undergoing a shift from simple decisions about cancer drugs, to integrated care pathways that treat the entire patient guided by new AI.

Until then, patients will continue to be locked into care pathways by insurance companies and SOC that ultimately lead to drug progression and death. There are now smarter ways but few patients or oncologists even know about them.

Learn about them: https://unchartedhealth.org

The best time to plant a tree was 20 years ago. The next best time is right now.
12/11/2021

The best time to plant a tree was 20 years ago. The next best time is right now.

The Reality of CancerCancer drugs are only effective until the cancer develops resistance to the drug… and cancers ALWAY...
11/11/2021

The Reality of Cancer

Cancer drugs are only effective until the cancer develops resistance to the drug… and cancers ALWAYS develop resistance to the drug.

Always. Every time. Always.

‘Remission’, only means that the drug has been temporarily effective in reducing the cancer and made it undetectable by our current tools. It’s still there, and it will come back. Our current technologies and tests just can’t determine accurately when that will be.

That single fact — that cancer always becomes resistant — means that the “silver bullet” drug to cure cancer will never exist, because the cancer will always adapt and develop a resistance to that drug over time.

Every time. Always.

Of course everyone already knows this. In fact, it’s so well understood that it’s called ‘standard of care’, and it’s why Chris’s diagnosis was terminal. This ‘standard care’ model is so reliable that oncologists are extremely accurate in predicting their patients drug and disease progression, and their death.

Chris’s treatment plan would look like every other cancer patient. He would be put on a chemotherapy drug continuously at what is called the Maximum Tolerable Dose (TAM). When the drug stopped being effective — as it always did — he would be switched to a new drug. When the available drugs for his cancer were exhausted, there would be no further way to hold off or control the cancer and it would explode, unchecked.

Learn we can change this: https://unchartehealth.org 👈

We're looking to care for the entire cancer patient.
06/11/2021

We're looking to care for the entire cancer patient.

03/11/2021
Data science and A.I. finally provide us a solution to move from manual healthcare delivery to technologies that work mo...
30/10/2021

Data science and A.I. finally provide us a solution to move from manual healthcare delivery to technologies that work more efficiently and better than humans ever can.

30/10/2021
30/10/2021

Meet the lead instructor and author of the Uncharted Cancer Patient Masterclass

Dr. Christopher Gregg, PhD, is a professor at the University of Utah, Primary Investigator at the Gregg Lab, a faculty member at the University of Utah Medical School, CSO at Storyline Health, and a stage IV cancer patient.

Dr. Gregg performed his Ph.D. studies at the University of Calgary in Canada in the field of neural stem cell biology. He was awarded the University of Calgary Chancellor’s Medal for his work on regenerative therapies and co-founded a biotechnology company called Stem Cell Therapeutics Corp. In 2006, he moved to Harvard University and was awarded a Human Frontiers Fellowship. At Harvard, he performed postdoctoral studies focused on developing genome analysis methods that can distinguish the expression of maternal and paternal gene copies in the brain. He was awarded the Eppendorf & Science Prize in Neurobiology in 2010 and his work was selected as one of the “Top 10 Breakthroughs of the Year” by the National Institutes of Mental Health Research. In 2012, he was selected to be a New York Stem Cell Foundation Robertson Investigator and is an assistant professor in the Department of Neurobiology & Anatomy and Human Genetics at the University of Utah School of Medicine. Dr. Gregg’s lab is developing new technologies and approaches to discover how the genome creates complex behavioral traits and is elucidating new mechanisms that contribute to brain disorders and diseases.

30/10/2021

Address


Alerts

Be the first to know and let us send you an email when The Uncharted Cancer Patient Masterclass posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to The Uncharted Cancer Patient Masterclass:

  • Want your practice to be the top-listed Clinic?

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram